Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Monoclonal Antibodies
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Monoclonal Antibodies

[0198-HAPT-11-3F7] Anti-Cow Haptoglobin Mouse Monoclonal IgG1 kappa, Clone HAPT-11-3F7 - 0.100 mG.
Anti-Cow Haptoglobin Mouse Monoclonal IgG1 kappa, Clone HAPT-11-3F7 - 0.100 mG.
261.00 € 261.0 EUR
[0513-DMAB8261-1mG.] Anti-Cefazolin monoclonal antibody, clone DI1090 1mG.
Anti-Cefazolin monoclonal antibody, clone DI1090 1mG.
2,715.00 € 2715.0 EUR
[0815-MU392A-5UC] Anti-CDX-2 monoclonal antibody [Clone: CDX2-88] - 0.5 ml
Anti-CDX-2 monoclonal antibody [Clone: CDX2-88] - 0.5 ml
1,505.00 € 1505.0 EUR
[0513-CABT-BL405] Anti-BAMBI monoclonal antibody [clone: 4D22-E2] - 100 ug.
Anti-BAMBI monoclonal antibody [clone: 4D22-E2] - 100 ug.
1,430.00 € 1430.0 EUR
[0087-KH011] Anti CML Monoclonal Antibody (Clone No. CMS-10) 50ug.
Anti CML Monoclonal Antibody (Clone No. CMS-10) 50ug.
829.00 € 829.0 EUR
[0992-HA601277] ALDH2 E. coli Rec. Mouse Monoclonal Antibody solution [Clone: 7-D8-R] - 100 ug. (Conc.: 1mG./ml)
ALDH2 E. coli Rec. Mouse Monoclonal Antibody solution [Clone: 7-D8-R] - 100 ug. (Conc.: 1mG./ml)
515.00 € 515.0 EUR
[0109-KNG17A12-100ug.] *Mouse Anti Human Kininogen Light Chain Monoclonal Clone 17A12 - 100 ug.
*Mouse Anti Human Kininogen Light Chain Monoclonal Clone 17A12 - 100 ug.
664.00 € 664.0 EUR
[0171-T9279] HPV-16 E6/E7 Stable Expression Hacat Cell Line Clone #11 - 1x106 cells / 1.0 ml
HPV-16 E6/E7 Stable Expression Hacat Cell Line Clone #11 - 1x106 cells / 1.0 ml
7,020.00 € 7020.0 EUR
[0247-OAMA00259] Gram Positive Bacteria Monoclonal Antibody [Clone: BDI380] - 1 mG.
Gram Positive Bacteria Monoclonal Antibody [Clone: BDI380] - 1 mG.
1,415.00 € 1415.0 EUR
[0401-B0025R-25ug.] Glypican 3 Monoclonal Antibody [clone 1G12] - 25ug.
Glypican 3 Monoclonal Antibody [clone 1G12] - 25ug.
663.00 € 663.0 EUR
[0071-NYBT2G1] Fibrin II beta (B15-42), (T)N-DSK, Fibrin II (B15-461), Clone: T2G1, Mab anti-Human; WB/ELISA - 0.2 mL
Fibrin II beta (B15-42), (T)N-DSK, Fibrin II (B15-461), Clone: T2G1, Mab anti-Human; WB/ELISA - 0.2 mL
2,227.00 € 2227.0 EUR
[0451-AS22 4819-1ml] Extensin Glycoprotein (monoclonal, clone JIM20)
Extensin Glycoprotein (monoclonal, clone JIM20)
331.00 € 331.0 EUR
[0882-AMM15109VCF-100ug.] DNA Polymerase iota (POLI) Mouse Monoclonal Antibody [Clone ID: LBI3B5] - 100ug.
DNA Polymerase iota (POLI) Mouse Monoclonal Antibody [Clone ID: LBI3B5] - 100ug.
880.00 € 880.0 EUR
[0937-BM941] Cyclosporin A Mouse Monoclonal Antibody [Clone ID: 4A3 (CSZ.22)] - 200 ug.
Cyclosporin A Mouse Monoclonal Antibody [Clone ID: 4A3 (CSZ.22)] - 200 ug.
914.00 € 914.0 EUR
[0247-OASA00565-50mG.] Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 50 mG.
Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 50 mG.
64,236.00 € 64236.0 EUR
[0247-OASA00565-5mG.] Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 5 mG.
Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 5 mG.
12,950.00 € 12950.0 EUR
[0247-OASA00565] Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 200 ug.
Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 200 ug.
820.00 € 820.0 EUR
[0247-OASA00565-10mG.] Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 10 mG.
Cyclosporin A Monoclonal Antibody [Clone: 4A3 (CSZ.22)] - 10 mG.
18,050.00 € 18050.0 EUR
[0171-C452] Custom 5’ UTR Reporter Lentiviral Vector Subcloning (Luc) - 1.0 μg - Subclone C098
Custom 5’ UTR Reporter Lentiviral Vector Subcloning (Luc) - 1.0 μg - Subclone C098
600.00 € 600.0 EUR
[0171-C451] Custom 5’ UTR Reporter Lentiviral Vector Subcloning (GFP) - 1.0 μg - Subclone C098
Custom 5’ UTR Reporter Lentiviral Vector Subcloning (GFP) - 1.0 μg - Subclone C098
600.00 € 600.0 EUR
  • 1
  • 2
  • 3
  • 4
  • 5

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)